/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Alpharma Inc\n \n\n\n\n\n
Nov 22 8:57 PM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Dec 29, 2008 5:48 PM EST
\n\n \n Standard & Poor's Announces Changes to U.S. Indices - PR Newswire\n \n \n
\n\n Nov 24, 2008 8:01 AM EST
\n\n \n King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion - PR Newswire\n \n \n
\n\n Oct 29, 2008 7:00 AM EDT
\n\n \n DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective - PR Newswire\n \n \n
\n\n Oct 15, 2008 1:31 PM EDT
\n\n \n National Family Partnership Designates October 27th 'Lock Your Meds' Day - PR Newswire\n \n \n
\n\n Sep 22, 2008 7:00 AM EDT
\n\n \n Alpharma to Develop and Commercialize DURECT's ELADUR(TM) Pain Patch - PR Newswire\n \n \n
\n\n Sep 09, 2008 3:35 PM EDT
\n\n \n Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting - PR Newswire\n \n \n
\n\n May 08, 2008 10:00 AM EDT
\n\n \n Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session - PR Newswire\n \n \n
\n
\n\n");